Biopharma
ByCan TrumpRx and Pfizer’s Discount Deal Reshape Prescription Drug Pricing in the U.S.?
Washington, D.C. The U.S. administration has announced the launch of TrumpRx, a federally operated digital platform designed to…
Is Sanofi Strengthening Its Adult Vaccine Strategy with a $2.2 Billion Dynavax Deal?
Paris, France Sanofi has taken a major step to strengthen its adult vaccines portfolio by announcing a $2.2…
Did 2025 Expose the Breaking Point of America’s Health Care System?
New reflections from healthcare leaders highlight how events in 2025 revealed deep structural weaknesses in the U.S. health…
U.S. FDA Approves JASCAYD® for Progressive Pulmonary Fibrosis – A New Treatment Option for Adults?
Boehringer Ingelheim announced that the U.S. Food and Drug Administration (FDA) has approved JASCAYD® (nerandomilast) tablets for the…
Can Jacobio Pharma and AstraZeneca Transform KRAS Cancer Treatment with $2 Billion Global Deal?
Shanghai/London Chinese biotech innovator Jacobio Pharma has entered a landmark global out-licensing agreement with AstraZeneca to advance its…
Is Samsung Biologics Set to Expand U.S. Operations with $280 Million GSK Acquisition?
Seoul/Washington, D.C. South Korea’s Samsung Biologics has announced its acquisition of its first U.S.-based drug production facility from…
